Click here to read the Cover Story, "Treatment landscape for presbyopia evolving toward noninvasive options."
With the forthcoming FDA approval and commercialization of eye drops that improve near vision, the presbyopia market is on the cusp of a pharmaceutical revolution.
Although it is difficult to predict the market penetration of any new product, we know for sure that the presbyopia market, with nearly 2 billion presbyopes today, is one of the largest in the world.
One question that remains is who will prescribe these medications and how. Although ophthalmologists and optometrists will